NHC Designates National Mental Illness Medical Centers in Beijing and Shanghai
The National Healthcare Commission (NHC) announced the establishment of national mental illness medical centers, designating...
Policy / Regulatory
Shenzhen Unveils Measures to Boost Biomedical and Medical Device Industries
Shenzhen’s municipal Development and Reform Commission has released a series of measures to promote the...
Sun Pharma’s Bicalutamide Supply Suspended in Multiple Chinese Regions
India-based Sun Pharma has suspended the supply of its bicalutamide to Beijing, Tianjin, Jilin, Shanghai,...
CDE Releases 61st Batch of Generic Reference Preparations, 34 New Specs Added
The Center for Drug Evaluation (CDE) has released the 61st batch of chemical generic reference...
Chinese Pharmacists Association Releases Draft VBP Drug Management Guidelines for Public Feedback
The Chinese Pharmacists Association (CPA) has released the “National Volume-based Procurement (VBP) Drug Management Expert...
NMPA Releases 56th Batch of GQCE Reference Drugs, Including 14 Injectables
The National Medical Products Administration (NMPA) has released the 56th batch of reference drugs for...
NHSA Issues New Medical Service Pricing Policy to Enhance Public Welfare and Innovation
The National Healthcare Security Administration (NHSA) has released a new notification on medical service pricing...
VBP Round 7 Drug Procurement Contract Awards Top Winners Revealed
China’s 7th national Volume-Based Procurement (VBP) round concluded with winning bids for 60 drug products...
China’s 2021 Healthcare Report Shows Rising Life Expectancy, Increased Medical Spending
China’s National Health Commission (NHC) released the “Healthcare Statistical Communique 2021,” revealing increased healthcare spending,...
NMPA Reclassifies Glucosamine Sulfate to OTC, Mandates Label Revisions
China’s National Medical Products Administration (NMPA) announced that potassium glucosamine sulfate has been reclassified from...
China’s JPO Launches VBP Round for Orthopedic Spine Consumables
China’s Joint Procurement Office (JPO) announced plans on July 11 to conduct a volume-based procurement...
China’s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids
China’s 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price...
NMPA Issues New Vaccine Manufacturing and Distribution Rules
China’s National Medical Products Administration (NMPA) has released the “Vaccine Manufacturing and Distribution Management Measures,”...
NHSA Sets 2022 Goals for Basic Medical Insurance Funding and Reforms
The National Healthcare Security Administration (NHSA), Ministry of Finance (MOF), and State Taxation Administration (STA)...
China Establishes Leadership Group to Combat Drug-Related Crimes
China’s State Council executive body released a notification regarding the establishment of a leadership group...
Wuxi Biologics Set to Be Removed from US Restricted Trade List
Wuxi Biologics (HKG: 2269) is reportedly on the verge of being removed from a US...
CDE Releases 60th Batch of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 60th batch of chemical generic reference...
Guangdong Releases 2022 Non-Immunization Vaccine Catalog (7th Batch)
The Guangdong Provincial Center for Disease Control and Prevention and Guangdong Medicine Exchange jointly released...
NHC Releases Technical Guidelines for Drug Clinical Evaluation
The National Health Commission (NHC) has released the “Technical Guidelines for Comprehensive Clinical Evaluation of...
Hainan Medical Products Administration Issues Guidelines for Imported Drug Management
The Hainan Medical Products Administration (HMPA) has released a set of guidelines that took effect...